These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 3171557)
1. Immunogenicity and pathogenicity of temperature-sensitive modified respiratory syncytial virus in adult volunteers. McKay E; Higgins P; Tyrrell D; Pringle C J Med Virol; 1988 Aug; 25(4):411-21. PubMed ID: 3171557 [TBL] [Abstract][Full Text] [Related]
2. Immunogenicity and pathogenicity of a triple temperature-sensitive modified respiratory syncytial virus in adult volunteers. Pringle CR; Filipiuk AH; Robinson BS; Watt PJ; Higgins P; Tyrrell DA Vaccine; 1993; 11(4):473-8. PubMed ID: 8470433 [TBL] [Abstract][Full Text] [Related]
3. Determinants of susceptibility to challenge and the antibody response of adult volunteers given experimental respiratory syncytial virus vaccines. Watt PJ; Robinson BS; Pringle CR; Tyrrell DA Vaccine; 1990 Jun; 8(3):231-6. PubMed ID: 2363300 [TBL] [Abstract][Full Text] [Related]
4. A comparison in chimpanzees of the immunogenicity and efficacy of live attenuated respiratory syncytial virus (RSV) temperature-sensitive mutant vaccines and vaccinia virus recombinants that express the surface glycoproteins of RSV. Crowe JE; Collins PL; London WT; Chanock RM; Murphy BR Vaccine; 1993 Nov; 11(14):1395-404. PubMed ID: 8310760 [TBL] [Abstract][Full Text] [Related]
5. Respiratory syncytial virus infection in owl monkeys: viral shedding, immunological response, and associated illness caused by wild-type virus and two temperature-sensitive mutants. Prince GA; Suffin SC; Prevar DA; Camargo E; Sly DL; London WT; Chanock RM Infect Immun; 1979 Dec; 26(3):1009-13. PubMed ID: 118925 [TBL] [Abstract][Full Text] [Related]
6. A further attenuated derivative of a cold-passaged temperature-sensitive mutant of human respiratory syncytial virus retains immunogenicity and protective efficacy against wild-type challenge in seronegative chimpanzees. Crowe JE; Bui PT; Davis AR; Chanock RM; Murphy BR Vaccine; 1994 Jul; 12(9):783-90. PubMed ID: 7975856 [TBL] [Abstract][Full Text] [Related]
7. Isolation and characterization of a highly attenuated respiratory syncytial virus (RSV) vaccine candidate by mutagenesis of the incompletely attenuated RSV A2 ts-1 NG-1 mutant virus. Hsu KH; Crowe JE; Lubeck MD; Davis AR; Hung PP; Chanock RM; Murphy BR Vaccine; 1995 Apr; 13(5):509-15. PubMed ID: 7543716 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of five temperature-sensitive mutants of respiratory syncytial virus in primates: II. Genetic analysis of virus recovered during infection. Belshe RB; Richardson LS; London WT; Sly DL; Camargo E; Prevar DA; Chanock RM J Med Virol; 1978; 3(2):101-10. PubMed ID: 104003 [TBL] [Abstract][Full Text] [Related]
9. Satisfactorily attenuated and protective mutants derived from a partially attenuated cold-passaged respiratory syncytial virus mutant by introduction of additional attenuating mutations during chemical mutagenesis. Crowe JE; Bui PT; London WT; Davis AR; Hung PP; Chanock RM; Murphy BR Vaccine; 1994 Jun; 12(8):691-9. PubMed ID: 8091846 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of two live, cold-passaged, temperature-sensitive respiratory syncytial virus vaccines in chimpanzees and in human adults, infants, and children. Karron RA; Wright PF; Crowe JE; Clements-Mann ML; Thompson J; Makhene M; Casey R; Murphy BR J Infect Dis; 1997 Dec; 176(6):1428-36. PubMed ID: 9395351 [TBL] [Abstract][Full Text] [Related]
11. Cold-passaged, temperature-sensitive mutants of human respiratory syncytial virus (RSV) are highly attenuated, immunogenic, and protective in seronegative chimpanzees, even when RSV antibodies are infused shortly before immunization. Crowe JE; Bui PT; Siber GR; Elkins WR; Chanock RM; Murphy BR Vaccine; 1995 Jun; 13(9):847-55. PubMed ID: 7483808 [TBL] [Abstract][Full Text] [Related]
13. Field trials on a live bovine respiratory syncytial virus vaccine in calves. Kubota M; Fukuyama S; Takamura K; Izumida A; Kodama K J Vet Med Sci; 1992 Oct; 54(5):957-62. PubMed ID: 1420579 [TBL] [Abstract][Full Text] [Related]
14. Live subgroup B respiratory syncytial virus vaccines that are attenuated, genetically stable, and immunogenic in rodents and nonhuman primates. Crowe JE; Bui PT; Firestone CY; Connors M; Elkins WR; Chanock RM; Murphy BR J Infect Dis; 1996 Apr; 173(4):829-39. PubMed ID: 8603960 [TBL] [Abstract][Full Text] [Related]
15. Generation of recombinant human parainfluenza virus type 1 vaccine candidates by importation of temperature-sensitive and attenuating mutations from heterologous paramyxoviruses. Newman JT; Riggs JM; Surman SR; McAuliffe JM; Mulaikal TA; Collins PL; Murphy BR; Skiadopoulos MH J Virol; 2004 Feb; 78(4):2017-28. PubMed ID: 14747566 [TBL] [Abstract][Full Text] [Related]
18. Growth and genetic stability of 4 temperature sensitive (ts) mutants of respiratory syncytial (RS) virus in newborn ferrets. Belshe RB; Richardson LS; Prevar DA; Camargo E; Chanock RM Arch Virol; 1978; 58(4):313-21. PubMed ID: 736795 [TBL] [Abstract][Full Text] [Related]
19. Prevention of bovine respiratory syncytial virus infection and clinical disease by vaccination. Verhoeff J; van Nieuwstadt AP Vet Rec; 1984 Nov; 115(19):488-92. PubMed ID: 6097014 [TBL] [Abstract][Full Text] [Related]
20. Antigen and polypeptide synthesis by temperature-sensitive mutants of respiratory syncytial virus. Pringle CR; Shirodaria PV; Gimenez HB; Levine S J Gen Virol; 1981 May; 54(Pt 1):173-83. PubMed ID: 7288405 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]